Definition of Crises in Medical Oncology: a Two-way Perspective of Patients and Caregivers. The COPE Study. (COPE)

Sponsor
Assistance Publique - Hôpitaux de Paris (Other)
Overall Status
Recruiting
CT.gov ID
NCT04736940
Collaborator
Canceropôle Ile de France (Other)
440
1
17
25.9

Study Details

Study Description

Brief Summary

Our objective is to identify the main crises facing the patients and caregivers in medical oncology and rank them by order of importance. Each group of participant will also express its perception of other participants' list of crises.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Hypotheses:

    Crises in medical oncology need to be precisely defined and classified. It should be the first step to offer appropriate support and solutions, improve communication and eventually improve quality of life/work for caregivers and for patients. Crises in medical oncology can imply all actors: doctors, nursing staff, psychologists, administration and patients. The definition of crisis and the level of importance of each situation may vary among these different groups. Nevertheless, we expect to identify shared characteristics. Patients' point of view which is rarely expressed will be collected. This work will also bring a better understanding of the perception each group have of each other.

    Objectives:

    Our main objective is to identify the main crises facing the patients and caregivers in medical oncology and rank them by order of importance. Each actor will also express its perception of other actors' list of crises.

    Methods:

    This work is led by an innovative multidisciplinary team of investigators associating patients, oncopsychologists, nurses and oncologists. Four study groups of participants are composed: a group of patients, a group of oncopsychologists, a group nurses and a group of oncologists.

    Demographic characteristics, general characteristics of the disease for the patients or type of exercise for the caregivers are collected.

    The first step of the project is to establish a list of crisis situations in each group consisting of 10 participants. The methodology applied is a modify Delphi in three rounds via a digital survey. In the first round, participants react to a pre-existing list, and are invited to complete it. The content is then analyzed, classified and developed into a list emailed for the second round.

    In a second round, the participants establish a ranking of the items on a scale of 1-6 (not important to extremely important). The group of patients will then rank the items added by the caregivers, and vice-versa.

    During the third and last round, the average of items is presented and the participants submit a new ranking. Individual interviews will be held to comment the results.

    The second step of the project enables to widen the study population, with a minimal objective of 100 participants per group. These new participants receive the list established in the first step to grade 20 items per frequency and importance.

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    440 participants
    Observational Model:
    Other
    Time Perspective:
    Prospective
    Official Title:
    Definition of Crises in Medical Oncology: a Two-way Perspective of Patients and Caregivers, a Prospective Observational Study.
    Actual Study Start Date :
    Jun 1, 2021
    Anticipated Primary Completion Date :
    Sep 1, 2022
    Anticipated Study Completion Date :
    Nov 1, 2022

    Arms and Interventions

    Arm Intervention/Treatment
    Patients

    Patients followed or currently treated for a solid or haematological neoplasia

    Doctors

    Medical oncologist or haematologist

    Paramedical staff

    Nurses or assistant nurses

    Oncopsychologist

    Psychologist specialised in the care of patients with cancer

    Outcome Measures

    Primary Outcome Measures

    1. List of crises ranked by order of importance in each group of paticipant [1 month]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • For patients: History of neoplasia or active treatment for a neoplasia of any localization of any phase.

    No restriction of center of treatment >18 years old Written consent must be obtained before any data collection

    • For caregivers Being a doctor, nurse, or a psychooncologist No restriction of age, or seniority

    Exclusion Criteria

    • For patients: Patients who participate 1st step cannot participate to 2nd step

    • For caregivers Caregivers who participate 1st step cannot participate to 2nd step.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 APHP Assistance Publique des Hôpitaux de Paris Paris France 75004

    Sponsors and Collaborators

    • Assistance Publique - Hôpitaux de Paris
    • Canceropôle Ile de France

    Investigators

    • Study Chair: Olivier HUILLARD, PhD, APHP Assistance Publique des Hôpitaux de Paris
    • Principal Investigator: Zahra CASTEL AJGAL, MD, APHP Assistance Publique des Hôpitaux de Paris

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Assistance Publique - Hôpitaux de Paris
    ClinicalTrials.gov Identifier:
    NCT04736940
    Other Study ID Numbers:
    • En attente de promotion
    First Posted:
    Feb 3, 2021
    Last Update Posted:
    Feb 18, 2022
    Last Verified:
    Feb 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Assistance Publique - Hôpitaux de Paris

    Study Results

    No Results Posted as of Feb 18, 2022